2021
DOI: 10.1007/s11064-021-03424-9
|View full text |Cite
|
Sign up to set email alerts
|

Overexpression of miR-378 Alleviates Chronic Sciatic Nerve Injury by Targeting EZH2

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
11
0

Year Published

2021
2021
2025
2025

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(11 citation statements)
references
References 41 publications
0
11
0
Order By: Relevance
“…CA1 treatment with siEZH2 downregulated CA1 LTP, visceral hypersensitivity, and anxiety in IBS-like rats. EZH2 is a target gene of miR-124-3p and other miRNAs (Li et al, 2020 ; Gao P. et al, 2021 ; Zhang et al, 2021 ). It is reasonable to consider that EZH2 is the common cellular pathway involved in many disorders, including cancer (Anwar et al, 2018 ), chronic pain (Yadav and Weng, 2017 ), and negative emotions (Yan et al, 2019 ; Li et al, 2022 ).…”
Section: Discussionmentioning
confidence: 99%
“…CA1 treatment with siEZH2 downregulated CA1 LTP, visceral hypersensitivity, and anxiety in IBS-like rats. EZH2 is a target gene of miR-124-3p and other miRNAs (Li et al, 2020 ; Gao P. et al, 2021 ; Zhang et al, 2021 ). It is reasonable to consider that EZH2 is the common cellular pathway involved in many disorders, including cancer (Anwar et al, 2018 ), chronic pain (Yadav and Weng, 2017 ), and negative emotions (Yan et al, 2019 ; Li et al, 2022 ).…”
Section: Discussionmentioning
confidence: 99%
“…However, in our study of GC patients with CIPN, we observed no difference in the expression levels of these miRNAs between the analyzed groups. On the other hand, it has been reported that miR-378 reduces neuropathic aches by negatively targeting enhancer of zeste homolog 2 (EZH2), and the miR-378/EZH2 axis plays an important role in the development of neuropathic pain [ 32 ]. Moreover, it has been reported that miR-378 is downregulated in rats with chronic constriction injury, and the overexpression of miR-378 reduces pain [ 33 ].…”
Section: Discussionmentioning
confidence: 99%
“…miR‐130a‐3p targets and downregulates insulin‐like growth factor‐1/insulin‐like growth factor‐1 receptor (IGF‐1/IGF‐1R) expression to alleviate SCI‐induced neuropathic pain by mitigating microglial activation and NF‐κB phosphorylation 45 . miR‐378 was decreased in CCI rats, inhibiting neuropathic pain development by targeting the enhancer of zeste homolog 2 (EZH2) 46 . EZH2 promotes neuropathic pain by increasing tumor necrosis factor‐alpha (TNF‐α), interleukin (IL)‐1β, and monocyte chemoattractant protein‐1 (MCP‐1) production.…”
Section: Studying Mirna Neuropathic Pain Mechanismsmentioning
confidence: 99%
“… 45 miR‐378 was decreased in CCI rats, inhibiting neuropathic pain development by targeting the enhancer of zeste homolog 2 (EZH2). 46 EZH2 promotes neuropathic pain by increasing tumor necrosis factor‐alpha (TNF‐α), interleukin (IL)‐1β, and monocyte chemoattractant protein‐1 (MCP‐1) production. Intrathecally injecting miRNA‐138 lentivirus can remarkably alleviate neuropathic pain in partial sciatic nerve ligation (pSNL) rats by suppressing toll‐like receptor 4 (TLR4) and macrophage inflammatory protein‐1 alpha (MIP‐1α)/C‐C chemokine receptor 1 (CCR1) signaling pathways.…”
Section: Studying Mirna Neuropathic Pain Mechanismsmentioning
confidence: 99%